Article Sidebar

PDF
Date Published: 19/02/2023
Abstract Views: 321
Views PDF: 370
DOI: https://doi.org/10.51298/vmj.v522i2.4378
Issue
Vol. 522 No. 2 (2023)
Section
Các bài báo
How to Cite
Trần, V. D., Hoàng, T. D., & Lưu, H. D. . (2023). LUNG CANCER SCREENING WITH LOW-DOSE CT IN HIGH-RISK PEOPLE: A SYSTEMATIC REVIEW. Vietnam Medical Journal, 522(2). https://doi.org/10.51298/vmj.v522i2.4378

LUNG CANCER SCREENING WITH LOW-DOSE CT IN HIGH-RISK PEOPLE: A SYSTEMATIC REVIEW

Văn Dũng Trần1,, Thùy Dung Hoàng1, Hồng Duy Lưu1
1 National cancer hospital

Main Article Content

Abstract

Objective: A symtematic review was conducted to verify whether screening could reduce lung cancer mortality in high-risk people and to determine the optimal screening program. Methods: Searching on PubMed and EMBASE, and relevant databases. Results: From 13 studies on lung cancer screening programs using low-dose CT scans were searched and selected through a systematic review of documents, in which criteria for selecting people at high risk, sample size, and number of screening visits were selected. Some of the key outcomes (lung cancer detection rates, early detection rates) and limitations of screening programs were combined.

Article Details

Keywords

screening; lung cancer; low-dose CT; systematic review

References

1. F et all Bray. Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. 2020:313.
2. Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L. Siegel, Lindsey A. Torre, Ahmedin Jemal. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians. 2018;68(6):394-424.
3. L. Babar, P. Modi, F. Anjum. Lung Cancer Screening. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright © 2022, StatPearls Publishing LLC.; 2022.
4. Natthaya Triphuridet, Claudia %J Lung Cancer: Targets Henschke, Therapy. Landscape on CT screening for lung cancer in Asia. 2019;10:107.
5. Nanda Horeweg, Ernst Th Scholten, Pim A. de Jong, Carlijn M. van der Aalst, Carla Weenink, Jan-Willem J. Lammers, et al. Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers. The Lancet Oncology. 2014;15(12):1342-50.
6. Thierry Blanchon, Jeanne-Marie Bréchot, Philippe A. Grenier, Gilbert R. Ferretti, Etienne Lemarié, Bernard Milleron, et al. Baseline results of the Depiscan study: A French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR). Lung Cancer. 2007;58(1):50-8.
7. U. Pastorino, M. Silva, S. Sestini, F. Sabia, M. Boeri, A. Cantarutti, et al. Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy. Annals of Oncology. 2019; 30(7):1162-9.
8. E. F. Patz, Jr., P. Pinsky, C. Gatsonis, J. D. Sicks, B. S. Kramer, M. C. Tammemägi, et al. Overdiagnosis in low-dose computed tomography screening for lung cancer. JAMA internal medicine. 2014;174(2):269-74.
9. M. Infante, S. Cavuto, F. R. Lutman, E. Passera, M. Chiarenza, G. Chiesa, et al. Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography. American journal of respiratory and critical care medicine. 2015;191(10):1166-75.
10. J. F. Rasmussen, V. Siersma, J. H. Pedersen, J. Brodersen. Psychosocial consequences in the Danish randomised controlled lung cancer screening trial (DLCST). Lung Cancer. 2015; 87(1):65-72.